advertisement
11.3.4 Betablocker (7)
Showing records 1 to 7
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker49017 Meta-analysis of α2-adrenergic agonists versus carbonic anhydrase inhibitors as adjunctive therapy
Cheng JW; Cheng SW; Yu DY; Wei RL; Lu GC
Current Medical Research and Opinion 2012; 28: 543-550
48973 Efficacy of Single Glaucoma Drug in Combined Timolol XE, Latanoprost and Brinzolamide Therapy: A Discontinuation Study
Kobayashi H
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 245-250
49003 Randomized Clinical Trial of the Efficacy and Safety of Preservative-free Tafluprost and Timolol in Patients With Open-Angle Glaucoma or Ocular Hypertension
Chabi A; Varma R; Tsai JC; Lupinacci R; Pigeon J; Baranak C; Noble L; Lines C; Ho TW
American Journal of Ophthalmology 2012; 153: 1187-1196
48791 Timogel® vs timolol 0.5% ophthalmic solution: efficacy, safety, and acceptance
Rolle T; Curto D; Alovisi C; Franzone M; Brogliatti B; Grignolo FM
European Journal of Ophthalmology 0; 22: 28-33
49016 New Mucoadhesive Chitosan Film for Ophthalmic Drug Delivery of Timolol Maleate: In Vivo Evaluation
Fulgê,ncio GD; Viana FA; Ribeiro RR; Yoshida MI; Faraco AG; Cunha-Jú,nior AD
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 350-358
49041 Generic versus brand-name North American topical glaucoma drops
Mammo ZN; Flanagan JG; James DF; Trope GE
Canadian Journal of Ophthalmology 2012; 47: 55-61
48981 The long-term outcomes of four alternative treatment strategies for primary open-angle glaucoma
Van Gestel A; Webers CA; Severens JL; Beckers HJ; Jansonius NM; Hendrikse F; Schouten JS
Acta Ophthalmologica 2012; 90: 20-31
